Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study

Objective Analysis of etanercept biosimilars in pediatric patients with juvenile idiopathic arthritis (JIA) in comparison with the etanercept originator in terms of efficacy and safety. Methods Patients diagnosed with JIA who started treatment with either the etanercept originator or a biosimilar af...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Franz Thiele, Ariane Klein, Anton Hospach, Daniel Windschall, Sonja Mrusek, J. Michael Ruehlmann, Gerd Horneff
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/1b438a336af34b0da53e55d8912c6ed0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares